Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this month.

Biogen Pays Forward Pharma $1.25B to License MS Drugs

Biogen Inc says it will pay Forward Pharma the sum to protect their company’s patents on multiple sclerosis drugs.

Biogen / Photo: Reuters
Biogen / Photo: Reuters

A January 17th Reuters article shared the latest information in the dispute between Biogen and Forward Pharma over patents for dimethyl fumarate, the active ingredient in Tecfidera, which generated $4 billion in revenue last year.

The deal entitles Biogen to a share of Forward’s intellectual property, but doesn’t settle the ongoing U.S. and E.U. patent battle. Biogen could still owe royalty payments on future Tecfidera sales if it loses the battle, but if they’re found valid, the company will owe nothing.

News of the deal spiked Forward’s shares 51%. The company plans to distribute a “substantial portion” of the funds to its shareholders in the form of stock buybacks and cash.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Break out of the ordinary: see what’s new in life sciences packaging
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us this month to experience a breakthrough for life sciences products.
REGISTER NOW!
Break out of the ordinary: see what’s new in life sciences packaging